160 related articles for article (PubMed ID: 30808144)
1. [Clinical diagnosis and treatment of eosinophilic otitis media].
Zhang YZ; Wei XY; Chen ZC; Sun M; Cheng Y; Gao Y; Chen FY; Hu J; Xu M; Zhang Q; Fan MY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):160-163. PubMed ID: 30808144
[No Abstract] [Full Text] [Related]
2. Eosinophilic otitis media; state-of-the-art diagnosis and treatment.
Iino Y
Auris Nasus Larynx; 2023 Aug; 50(4):479-489. PubMed ID: 36528403
[TBL] [Abstract][Full Text] [Related]
3. New Insights into Eosinophilic Otitis Media.
Kanazawa H; Yoshida N; Iino Y
Curr Allergy Asthma Rep; 2015 Dec; 15(12):76. PubMed ID: 26546407
[TBL] [Abstract][Full Text] [Related]
4. Intractable otitis media - Pathogenesis and treatment of Eosinophilic otitis media (EOM) and otitis media with Antineutrophil cytoplasmic antibody (ANCA) -associated vasculitis (OMAAV).
Yoshida N
Auris Nasus Larynx; 2023 Apr; 50(2):171-179. PubMed ID: 35934599
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of eosinophilic otitis media: a systematic review.
Chen T; Ashman PE; Bojrab DI; Johnson AP; Hong RS; Benson B; Svider PF
Acta Otolaryngol; 2021 Jun; 141(6):579-587. PubMed ID: 33825596
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media.
Iino Y; Takahashi E; Ida S; Kikuchi S
Auris Nasus Larynx; 2019 Apr; 46(2):196-203. PubMed ID: 30122651
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
Iino Y; Kakizaki K; Katano H; Saigusa H; Kanegasaki S
Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease.
Iino Y; Tomioka-Matsutani S; Matsubara A; Nakagawa T; Nonaka M
Auris Nasus Larynx; 2011 Aug; 38(4):456-61. PubMed ID: 21251776
[TBL] [Abstract][Full Text] [Related]
9. Eosinophilic otitis media: a new middle ear disease entity.
Iino Y
Curr Allergy Asthma Rep; 2008 Nov; 8(6):525-30. PubMed ID: 18940145
[TBL] [Abstract][Full Text] [Related]
10. IgG4 Expression in Patients with Eosinophilic Otitis Media.
Takahashi M; Oka A; Kariya S; Gion Y; Sato Y; Iwasaki S; Oyamada S; Matsubara A; Okano M
ORL J Otorhinolaryngol Relat Spec; 2021; 83(3):167-171. PubMed ID: 33691317
[TBL] [Abstract][Full Text] [Related]
11. [Current in eosinophilic otitis media].
Du YL; Duan QC; Ma FR
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(6):489-492. PubMed ID: 29871294
[TBL] [Abstract][Full Text] [Related]
12. Eosinophilic otitis media: CT and MRI findings and literature review.
Chung WJ; Lee JH; Lim HK; Yoon TH; Cho KJ; Baek JH
Korean J Radiol; 2012; 13(3):363-7. PubMed ID: 22563277
[TBL] [Abstract][Full Text] [Related]
13. Eosinophilic otitis media diagnosis using flow cytometric immunophenotyping.
Saliba I; Alzahrani M; Weng X; Bestavros A
Acta Otolaryngol; 2018 Feb; 138(2):110-115. PubMed ID: 29037099
[TBL] [Abstract][Full Text] [Related]
14. Eosinophilic Otitis Media: the Aftermath of Eosinophil Extracellular Trap Cell Death.
Ueki S; Ohta N; Takeda M; Konno Y; Hirokawa M
Curr Allergy Asthma Rep; 2017 May; 17(5):33. PubMed ID: 28455742
[TBL] [Abstract][Full Text] [Related]
15. Periostin in middle ear mucosa according to eosinophilic otitis media severity: Middle ear pathology-based treatment.
Esu Y; Masuda M; Yoshida N
Auris Nasus Larynx; 2020 Aug; 47(4):527-535. PubMed ID: 32586742
[TBL] [Abstract][Full Text] [Related]
16. Use of IL-5 Inhibitor Benralizumab as a Novel Therapy for Eosinophilic Otitis Media: Clinical Capsule and Review of Literature.
Chow K; Cosetti MK
Otol Neurotol; 2020 Feb; 41(2):e238-e240. PubMed ID: 31923159
[TBL] [Abstract][Full Text] [Related]
17. Intractable otitis media with eosinophils: Importance of diagnosis and validity of treatment for hearing preservation.
Nakagawa T; Matsubara A; Shiratsuchi H; Kakazu Y; Nakashima T; Koike K; Umezaki T; Komune S
ORL J Otorhinolaryngol Relat Spec; 2006; 68(2):118-22. PubMed ID: 16446559
[TBL] [Abstract][Full Text] [Related]
18. Treatment of eosinophilic otitis media with pegylated interferon-α 2a and 2b.
Neff BA; Voss SG; Carlson ML; O'Brien EK; Butterfield JH
Laryngoscope; 2017 May; 127(5):1208-1216. PubMed ID: 27667784
[TBL] [Abstract][Full Text] [Related]
19. Proposal of a Treatment Strategy for Eosinophilic Otitis Media Based on Middle Ear Condition.
Esu Y; Iino Y; Masuda M; Kanazawa H; Yoshida N
Otol Neurotol; 2018 Sep; 39(8):e671-e678. PubMed ID: 30113562
[TBL] [Abstract][Full Text] [Related]
20. Role of IgE in eosinophilic otitis media.
Iino Y
Allergol Int; 2010 Sep; 59(3):233-238. PubMed ID: 20657163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
